Anaplastic astrocytoma

Search Trials
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
Status:
Recruiting
Last Changed:
Aug 25, 2021
First Changed:
Aug 31, 2016
Disease(s):
Glioblastoma Multiforme
Intervention(s):
Cabozantinib
Quality of Life and Patient Needs in Advanced High Grade Gliomas
Status:
Active, not recruiting
Last Changed:
Sep 9, 2021
First Changed:
Sep 9, 2021
Disease(s):
Quality of Life
Intervention(s):
Phone interviews
The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma
Status:
Terminated
Last Changed:
Feb 7, 2020
First Changed:
Apr 10, 2015
Disease(s):
Glioblastoma Multiforme
Intervention(s):
Toca 511Toca FCLomustineTemozolomideBevacizumab
A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma
Status:
Recruiting
Last Changed:
Jun 6, 2022
First Changed:
Jul 27, 2021
Disease(s):
Medulloblastoma
Intervention(s):
SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 yearsSurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 yearsSurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Status:
Terminated
Last Changed:
Jun 11, 2010
First Changed:
Jan 27, 2003
Disease(s):
Brain and Central Nervous System Tumors
Intervention(s):
filgrastimsargramostimtherapeutic autologous lymphocytesO6-benzylguaninecarmustinetemozolomidein vitro-treated peripheral blood stem cell transplantation

Connect. Empower. Inspire.